AbbVie Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for AbbVie Inc. (ABBV), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are ABBV insiders buying or selling?
In the last 12 months, AbbVie Inc. insiders reported 0 open-market purchases ($0) and 4 sales ($18.9M) — net selling of $18.9M. Since February 2018, Trabud has recorded 124 Form 4 filings for ABBV: 16 buys ($16.1M) and 108 sells ($664.7M).
Source: SEC EDGAR Form 4
What stands out
- No AbbVie Inc. insider made an open-market purchase in the last 12 months; the 4 reported open-market sales totaled $18.9M.
Key Statistics (February 2018 – Aug 18, 2026)
Total Form 4 filings
124
SEC EDGAR
Insider filers
21
Insider buys (16)
$16.1M
Insider sells (108)
$664.7M
Insider sentiment
Net sellingNet insider flow of $648.6M in net selling since February 2018, and $18.9M in net selling over the last 12 months.
Recent ABBV insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Aug 18, 2026 | Nicholas Donoghoe | EVP, CHIEF BUS/STRAT OFFICER | Sale | 32.7K | $250.00 | $8.2M | SEC ↗ |
| Mar 6, 2026 | David Ryan Purdue | SVP, Controller | Sale | 5.2K | $233.56 | $1.2M | SEC ↗ |
| Mar 3, 2026 | Perry C Siatis | EVP, GC AND SECRETARY | Sale | 18.7K | $234.39 | $4.4M | SEC ↗ |
| Feb 27, 2026 | Perry C Siatis | EVP, GC AND SECRETARY | Sale | 22.4K | $230.00 | $5.1M | SEC ↗ |
| Aug 14, 2025 | Azita Saleki-Gerhardt | EVP, CHIEF OPERATIONS OFFICER | Sale | 42.4K | $198.42 | $8.4M | SEC ↗ |
| Aug 7, 2025 | Nicholas Donoghoe | EVP, CHIEF BUS/STRAT OFFICER | Sale | 13.3K | $198.51 | $2.6M | SEC ↗ |
| Apr 2, 2025 | Jeffrey Ryan Stewart | EVP, CHIEF COMMERCIAL OFFICER | Sale | 58.8K | $210.08 | $12.4M | SEC ↗ |
| Mar 18, 2025 | Scott T Reents | EVP, CHIEF FINANCIAL OFFICER | Sale | 17.6K | $212.34 | $3.7M | SEC ↗ |
| Mar 4, 2025 | Richard A Gonzalez | Director | Sale | 98.6K | $205.45 | $20.3M | SEC ↗ |
| Mar 4, 2025 | Perry C Siatis | EVP, GC AND SECRETARY | Sale | 27.9K | $208.69 | $5.8M | SEC ↗ |
| Mar 4, 2025 | Timothy J. Richmond | EVP, CHIEF HR OFFICER | Sale | 21.3K | $210.45 | $4.5M | SEC ↗ |
| Feb 28, 2025 | Kevin K Buckbee | SVP, CONTROLLER | Sale | 18.9K | $203.41 | $3.9M | SEC ↗ |
| Feb 28, 2025 | Timothy J. Richmond | EVP, CHIEF HR OFFICER | Sale | 29.9K | $202.90 | $6.1M | SEC ↗ |
| Feb 24, 2025 | Perry C Siatis | EVP, GC AND SECRETARY | Sale | 5.8K | $197.90 | $1.1M | SEC ↗ |
| Dec 18, 2024 | Kevin K Buckbee | SVP, CONTROLLER | Sale | 1.8K | $172.24 | $310.0K | SEC ↗ |
| Aug 7, 2024 | Richard A Gonzalez | EXECUTIVE CHAIRMAN OF BOARD | Sale | 66.5K | $186.52 | $12.4M | SEC ↗ |
| Jul 19, 2024 | Richard A Gonzalez | EXECUTIVE CHAIRMAN OF BOARD | Sale | 282.8K | $175.00 | $49.5M | SEC ↗ |
| Mar 22, 2024 | Nicholas Donoghoe | EVP, CHIEF BUS/STRAT OFFICER | Sale | 21.1K | $176.30 | $3.7M | SEC ↗ |
| Mar 20, 2024 | Jeffrey Ryan Stewart | EVP, CHIEF COMMERCIAL OFFICER | Sale | 58.9K | $178.79 | $10.5M | SEC ↗ |
| Mar 5, 2024 | Timothy J. Richmond | EVP, CHIEF HR OFFICER | Sale | 75.7K | $177.27 | $13.4M | SEC ↗ |
| Mar 1, 2024 | Scott T Reents | EVP, CHIEF FINANCIAL OFFICER | Sale | 14.1K | $177.44 | $2.5M | SEC ↗ |
| Mar 1, 2024 | Kevin K Buckbee | SVP, CONTROLLER | Sale | 5.1K | $176.65 | $908.7K | SEC ↗ |
| Mar 1, 2024 | Robert A. Michael | PRES & CHIEF OPERATING OFFICER | Sale | 68.9K | $176.45 | $12.2M | SEC ↗ |
| Mar 1, 2024 | Perry C Siatis | EVP, GC AND SECRETARY | Sale | 9.9K | $177.39 | $1.8M | SEC ↗ |
| Mar 1, 2024 | Richard A Gonzalez | CHAIRMAN OF THE BOARD AND CEO | Sale | 138.6K | $177.27 | $24.6M | SEC ↗ |
Showing the 25 most recent of 124 Form 4 filings for AbbVie Inc..
Most active ABBV insiders
- Timothy J. Richmond13 filings
- Azita Saleki-Gerhardt10 filings
- Elaine K. Sorg10 filings
- Jeffrey Ryan Stewart10 filings
- Richard A Gonzalez10 filings
Ask anything about ABBV insider activity
Use Trabud's AI agent to query AbbVie Inc.'s Form 4 history in plain English — "Show me ABBV CEO purchases this year" or compare it against any other ticker.
Open the AI agentABBV insider trading FAQ
Are AbbVie Inc. insiders buying or selling?
In the last 12 months, AbbVie Inc. insiders reported 0 open-market purchases ($0) and 4 sales ($18.9M) — net selling of $18.9M. Since February 2018, Trabud has recorded 124 Form 4 filings for ABBV: 16 buys ($16.1M) and 108 sells ($664.7M). Over the full record that is net selling of $648.6M.
How many insiders trade ABBV stock?
21 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for AbbVie Inc.. The most recent filing was accepted on Aug 18, 2026.
Where does Trabud get ABBV insider trading data?
All ABBV insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.